/CI
CI Stock - Cigna Corporation
Healthcare|Medical - Healthcare PlansNYSE
$271.89-0.77%
$2.11 (-0.77%) • Dec 19
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.33
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).88
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+19.0%upside
Target: $323.55
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$269.17 – $274.61
TARGET (TP)$323.45
STOP LOSS$250.14
RISK/REWARD1:2.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.26
52W High$350.00
52W Low$239.51
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $247.12B | $195.26B | $180.52B | $174.07B | $160.40B |
| Gross Profit | $25.96B | $25.18B | $23.50B | $22.95B | $24.21B |
| Gross Margin | 10.5% | 12.9% | 13.0% | 13.2% | 15.1% |
| Operating Income | $9.42B | $8.54B | $8.45B | $7.94B | $8.15B |
| Net Income | $3.43B | $5.16B | $6.70B | $5.37B | $8.46B |
| Net Margin | 1.4% | 2.6% | 3.7% | 3.1% | 5.3% |
| EPS | $12.25 | $17.57 | $21.66 | $15.89 | $23.17 |
Company Overview
The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Visit WebsiteRating Distribution
Strong Buy
1
6%
Buy / Outperform
9
56%
Hold / Neutral
6
38%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
10 Bullish6 Neutral/Bearish
Price Targets
$338
Average Target
↑ 24.4% Upside
Now
$270
Low
$338
Average
$400
High
Based on 23 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 14th 2025 | Goldman | Initiation | Buy | $370 |
| February 6th 2025 | Bernstein | Downgrade | Market Perform | $323 |
| June 26th 2024 | Piper Sandler | Initiation | Overweight | $400 |
| May 30th 2024 | Robert W. Baird | Initiation | Outperform | $388 |
| March 6th 2024 | Barclays | Initiation | Overweight | $393 |
| February 5th 2024 | Cantor Fitzgerald | Upgrade | Overweight | $372← $334 |
| February 5th 2024 | RBC Capital Mkts | Upgrade | Outperform | $354← $327 |
| February 1st 2024 | Deutsche Bank | Upgrade | Buy | $370← $355 |
| January 4th 2024 | Bernstein | Upgrade | Outperform | $372← $330 |
| December 11th 2023 | Jefferies | Upgrade | Buy | $341← $335 |
| August 18th 2023 | Edward Jones | Downgrade | Hold | - |
| June 6th 2023 | BofA Securities | Upgrade | Buy | $320 |
| April 21st 2023 | Cantor Fitzgerald | Initiation | Neutral | $285 |
| April 5th 2023 | Raymond James | Upgrade | Strong Buy | $350 |
| January 3rd 2023 | Wells Fargo | Downgrade | Equal Weight | $355← $370 |
Earnings History & Surprises
CIBeat Rate
94%
Last 18 quarters
Avg Surprise
+4.1%
EPS vs Estimate
Beats / Misses
17/1
Last 12 quarters
Latest EPS
$7.83
Q4 2025
EPS Surprise History
Q1 24
+3.8%
$6.79vs$6.54
Q2 24
+4.0%
$6.47vs$6.22
Q3 24
+4.8%
$6.72vs$6.41
Q4 24
+3.9%
$7.51vs$7.23
Q1 25
-15.3%
$6.64vs$7.84
Q2 25
+6.1%
$6.74vs$6.35
Q3 25
+0.6%
$7.20vs$7.16
Q4 25
+2.5%
$7.83vs$7.64
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 30, 2026 | — | — | — | — |
Q1 2026 | Jan 29, 2026 | $7.90 | — | — | — |
Q4 2025 | Oct 30, 2025 | $7.64 | $7.83 | +2.5% | ✓ BEAT |
Q3 2025 | Jul 31, 2025 | $7.16 | $7.20 | +0.6% | ✓ BEAT |
Q2 2025 | May 2, 2025 | $6.35 | $6.74 | +6.1% | ✓ BEAT |
Q1 2025 | Jan 30, 2025 | $7.84 | $6.64 | -15.3% | ✗ MISS |
Q4 2024 | Oct 31, 2024 | $7.23 | $7.51 | +3.9% | ✓ BEAT |
Q3 2024 | Aug 1, 2024 | $6.41 | $6.72 | +4.8% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $6.22 | $6.47 | +4.0% | ✓ BEAT |
Q1 2024 | Feb 2, 2024 | $6.54 | $6.79 | +3.8% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $6.66 | $6.77 | +1.7% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $6.02 | $6.13 | +1.8% | ✓ BEAT |
Q2 2023 | May 5, 2023 | $5.22 | $5.41 | +3.6% | ✓ BEAT |
Q1 2023 | Feb 3, 2023 | $4.86 | $4.96 | +2.1% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $5.70 | $6.04 | +6.0% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $5.48 | $6.22 | +13.5% | ✓ BEAT |
Q2 2022 | May 6, 2022 | $5.13 | $6.01 | +17.2% | ✓ BEAT |
Q1 2022 | Feb 3, 2022 | $4.68 | $4.77 | +1.9% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $5.23 | $5.73 | +9.6% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $4.96 | $5.24 | +5.6% | ✓ BEAT |
Latest News
Trump Administration Proposes Rule Banning Medicaid And CHIP From Paying For Gender Affirming Care
➖ NeutralBenzinga•Dec 18, 2025, 04:27 PM•Also: , ,
Shares of healthcare stocks are trading higher amid the Republican healthcare bill failing to win enough votes to advance in the Senate.
📈 PositiveBenzinga•Dec 11, 2025, 07:46 PM•Also: , ,
Reuters: Some States Operating ACA Marketplaces Say Enrollment Is Significantly Down From Same Period Last Year, California Says ACA Enrollment Down By 33% vs Last Year
📉 NegativeBenzinga•Nov 24, 2025, 07:22 PM•Also: , ,
Politico Reported The White House To Propose A Two-year Extension Of Obamacare Subsidies With New Limits On Eligibility
➖ NeutralBenzinga•Nov 24, 2025, 11:16 AM•Also: , ,
Cigna Exec Says It Is Working With Novo, Lilly On Changes In GLP-1 Drug Prices After White House Deal
📈 PositiveBenzinga•Nov 12, 2025, 04:30 PM•Also: ,
Bernstein Maintains Market Perform on Cigna Group, Lowers Price Target to $294
➖ NeutralBenzinga•Nov 12, 2025, 01:29 PM
Watching Health Care Stocks; Traders Circulate Report Saying Speaker Johnson Says Won't Promise A Vote On Health-Care Subsidies
📉 NegativeBenzinga•Nov 6, 2025, 03:53 PM•Also: , ,
Cigna Appoints Amy Flaster As Chief Medical Officer, Effective Nov. 1, 2025
➖ NeutralBenzinga•Nov 6, 2025, 12:28 PM
Wells Fargo Maintains Equal-Weight on Cigna Group, Lowers Price Target to $300
📉 NegativeBenzinga•Nov 5, 2025, 03:07 PM
TD Cowen Maintains Buy on Cigna Group, Lowers Price Target to $333
➖ NeutralBenzinga•Nov 4, 2025, 06:35 PM
Goldman Sachs Maintains Buy on Cigna Group, Lowers Price Target to $330
➖ NeutralBenzinga•Nov 4, 2025, 04:59 PM
JP Morgan Maintains Overweight on Cigna Group, Lowers Price Target to $375
➖ NeutralBenzinga•Nov 4, 2025, 03:23 PM
Barclays Maintains Overweight on Cigna Group, Lowers Price Target to $300
➖ NeutralBenzinga•Nov 3, 2025, 02:30 PM•Also:
Cigna falls despite earnings beats on pharmacy benefit margin concerns
📉 NegativeSeeking Alpha•Oct 30, 2025, 06:42 PM
Cigna shares are trading lower after the company said it expects margin pressure in its pharmacy benefit service segment over the next two years.
📉 NegativeBenzinga•Oct 30, 2025, 03:39 PM
Cigna Q3 Total Pharmacy Customers 122.49M (+2% YoY); Total Customer Relationships 182.5M
📈 PositiveBenzinga•Oct 30, 2025, 10:05 AM
Cigna CEO David Cordani Said, "Our new market-defining rebate-free pharmacy benefit model will further lower costs and enhance transparency for the benefit of those we serve."
📈 PositiveBenzinga•Oct 30, 2025, 10:03 AM
Cigna Group Reaffirms FY2025 Adj. EPS Outlook Of More Than $29.60 vs $29.63 Est
➖ NeutralBenzinga•Oct 30, 2025, 10:02 AM
Cigna Group Q3 Adj. EPS $7.83 Beats $7.65 Estimate, Sales $69.740B Beat $67.110B Estimate
📈 PositiveBenzinga•Oct 30, 2025, 10:01 AM
Cigna Group's Evernorth Introduces New Pharmacy Benefit Era Offering Lower Drug Costs, Real-Time Transparency, And Better Experiences For American Patients
📈 PositiveBenzinga•Oct 27, 2025, 10:26 AM
Frequently Asked Questions about CI
What is CI's current stock price?
Cigna Corporation (CI) is currently trading at $271.89 per share. The stock has moved -0.77% today.
What is the analyst price target for CI?
The average analyst price target for CI is $323.45, based on 1 analyst.
What sector is Cigna Corporation in?
Cigna Corporation operates in the Healthcare sector, specifically within the Medical - Healthcare Plans industry. The company is traded on the NYSE exchange.
What is CI's market cap?
Cigna Corporation has a market capitalization of $72.63 billion, making it a large-cap company.
Does CI pay dividends?
No, Cigna Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBDX
Becton, Dickinson and Company
$195.59
Mkt Cap: $56.3B
CAH
Cardinal Health, Inc.
$202.95
Mkt Cap: $48.2B
CNC
Centene Corporation
$39.03
Mkt Cap: $19.2B
COR
Cencora, Inc.
$340.93
Mkt Cap: $66.1B
CVS
CVS Health Corporation
$77.72
Mkt Cap: $98.7B
ELV
Elevance Health Inc.
$340.69
Mkt Cap: $75.7B
HUM
Humana Inc.
$259.40
Mkt Cap: $31.2B
IDXX
IDEXX Laboratories, Inc.
$700.34
Mkt Cap: $55.9B
REGN
Regeneron Pharmaceuticals, Inc.
$767.96
Mkt Cap: $79.3B
ZTS
Zoetis Inc.
$122.24
Mkt Cap: $53.9B
Explore stocks similar to CI for comparison